Rotavirus Vaccines
"Rotavirus Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent infection with ROTAVIRUS.
Descriptor ID |
D022243
|
MeSH Number(s) |
D20.215.894.899.760
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Rotavirus Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Rotavirus Vaccines".
This graph shows the total number of publications written about "Rotavirus Vaccines" by people in this website by year, and whether "Rotavirus Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 1 | 0 | 1 | 2009 | 2 | 0 | 2 | 2012 | 1 | 0 | 1 | 2013 | 2 | 1 | 3 | 2014 | 1 | 0 | 1 | 2016 | 0 | 2 | 2 | 2017 | 2 | 0 | 2 | 2020 | 1 | 0 | 1 | 2021 | 2 | 0 | 2 | 2022 | 1 | 0 | 1 | 2025 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Rotavirus Vaccines" by people in Profiles.
-
DeSilva MB, Haapala J, Vazquez-Benitez G, Daley MF, Lewin B, Klein NP, Liles EG, Jackson LA, Williams JTB, Donahue JG, Katherine Yih W, Kharbanda EO. COVID-19 and Completion of Select Routine Childhood Vaccinations. Pediatrics. 2025 Apr 01; 155(4).
-
P KK, Chiteti SR, Aileni VK, Babji S, Blackwelder WC, Kumar A, Vagha J, Nayak U, Mitra M, D N, Kar S, Yadav S, Naidu S, Mahantshetti N, Khalatkar V, Mohapatra S, Purthi PK, Sharma P, Kannan A, Dhongade RK, Prasad SD, Ella R, Vadrevu KM. Phase III randomized clinical studies to evaluate the immunogenicity, lot-to-lot consistency, and safety of ROTAVAC? liquid formulations (ROTAVAC 5C & 5D) and non-inferiority comparisons with licensed ROTAVAC? (frozen formulation) in healthy infants. Hum Vaccin Immunother. 2023 12 15; 19(3):2278346.
-
Kamidani S, Panagiotakopoulos L, Licata C, Daley MF, Yih WK, Zerbo O, Tseng HF, DeSilva MB, Nelson JC, Groom HC, Williams JTB, Hambidge SJ, Donahue JG, Belay ED, Weintraub ES. Kawasaki Disease Following the 13-valent Pneumococcal Conjugate Vaccine and Rotavirus Vaccines. Pediatrics. 2022 12 01; 150(6).
-
Kempe A, O'Leary ST, Cortese MM, Crane LA, Cataldi JR, Brtnikova M, Beaty BL, Hurley LP, Gorman C, Tate JE, St Pierre JL, Lindley MC. Why Aren't We Achieving High Vaccination Rates for Rotavirus Vaccine in the United States? Acad Pediatr. 2022 May-Jun; 22(4):542-550.
-
Liles E, Irving SA, Dandamudi P, Belongia EA, Daley MF, DeStefano F, Jackson LA, Jacobsen SJ, Kharbanda E, Klein NP, Weintraub E, Naleway AL. Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination. Vaccine. 2021 06 16; 39(27):3614-3620.
-
Glanz JM, Clarke CL, Xu S, Daley MF, Shoup JA, Schroeder EB, Lewin BJ, McClure DL, Kharbanda E, Klein NP, DeStefano F. Association Between Rotavirus Vaccination and Type 1 Diabetes in Children. JAMA Pediatr. 2020 05 01; 174(5):455-462.
-
Ella R, Babji S, Ciarlet M, Blackwelder WC, Vadrevu KM. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC? in comparison with a licensed rotavirus vaccine in healthy infants. Vaccine. 2019 07 18; 37(31):4407-4413.
-
Clark A, Black R, Tate J, Roose A, Kotloff K, Lam D, Blackwelder W, Parashar U, Lanata C, Kang G, Troeger C, Platts-Mills J, Mokdad A, Sanderson C, Lamberti L, Levine M, Santosham M, Steele D. Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements. PLoS One. 2017; 12(9):e0183392.
-
Uprety P, Lindsey JC, Levin MJ, Rainwater-Lovett K, Ziemniak C, Bwakura-Dangarembizix M, Kaplan SS, Nelson M, Zadzilka A, Weinberg A, Persaud D. Inflammation and Immune Activation in Antiretroviral-Treated Human Immunodeficiency Virus Type 1-Infected African Infants and Rotavirus Vaccine Responses. J Infect Dis. 2017 03 15; 215(6):928-932.
-
Levin MJ, Lindsey JC, Kaplan SS, Schimana W, Lawrence J, McNeal MM, Bwakura-Dangarembizi M, Ogwu A, Mpabalwani EM, Sato P, Siberry G, Nelson M, Hille D, Weinberg GA, Weinberg A. Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa. AIDS. 2017 01 02; 31(1):49-59.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|